India
· Delayed Price · Currency is INR Torrent Pharmaceuticals Statistics
Total Valuation
NSE:TORNTPHARM has a market cap or net worth of INR 1.05 trillion. The enterprise value is 1.07 trillion.
| Market Cap | 1.05T |
| Enterprise Value | 1.07T |
Important Dates
The last earnings date was Monday, January 27, 2025.
| Earnings Date | Jan 27, 2025 |
| Ex-Dividend Date | Jan 31, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 105.62M |
Valuation Ratios
The trailing PE ratio is 56.62.
| PE Ratio | 56.62 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 37.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 57.64 |
| EV / Sales | 9.50 |
| EV / EBITDA | 29.03 |
| EV / EBIT | 37.59 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | n/a |
| Interest Coverage | 10.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.35% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.19M |
| Profits Per Employee | 1.18M |
| Employee Count | 15,718 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.01% in the last 52 weeks. The beta is 0.26, so NSE:TORNTPHARM's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +27.01% |
| 50-Day Moving Average | 3,313.08 |
| 200-Day Moving Average | 3,155.50 |
| Relative Strength Index (RSI) | 35.94 |
| Average Volume (20 Days) | 368,475 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:TORNTPHARM had revenue of INR 113.02 billion and earned 18.62 billion in profits. Earnings per share was 55.03.
| Revenue | 113.02B |
| Gross Profit | 85.78B |
| Operating Income | 28.55B |
| Pretax Income | 26.39B |
| Net Income | 18.62B |
| EBITDA | 36.75B |
| EBIT | 28.55B |
| Earnings Per Share (EPS) | 55.03 |
Balance Sheet
The company has 12.35 billion in cash and 31.26 billion in debt, giving a net cash position of -18.91 billion.
| Cash & Cash Equivalents | 12.35B |
| Total Debt | 31.26B |
| Net Cash | -18.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 75.04B |
| Book Value Per Share | 221.48 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.90%, with operating and profit margins of 25.26% and 16.48%.
| Gross Margin | 75.90% |
| Operating Margin | 25.26% |
| Pretax Margin | 23.35% |
| Profit Margin | 16.48% |
| EBITDA Margin | 32.52% |
| EBIT Margin | 25.26% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.00%.
| Dividend Per Share | 32.00 |
| Dividend Yield | 1.00% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.97% |
| Earnings Yield | 1.77% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jul 8, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |